DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells

PURPOSE: The combination of systemic cisplatin with local and regional radiotherapy as primary treatment of head and neck squamous cell carcinoma (HNSCC) leads to cure in approximately half of the patients. The addition of cisplatin has significant effects on outcome, but despite extensive research...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Martens-de Kemp, Sanne R., Dalm, Simone U., Wijnolts, Fiona M. J., Brink, Arjen, Honeywell, Richard J., Peters, Godefridus J., Braakhuis, Boudewijn J. M., Brakenhoff, Ruud H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2013
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629194/
https://ncbi.nlm.nih.gov/pubmed/23613873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061555
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk